POSTS

Post by FDAzilla | August 29, 2019

Gaining GMP Expertise: Govzilla Adds Jane Wastl as Senior GMP Quality Expert

Govzilla announces the addition of Jane Wastl as Senior GMP Quality Expert to the Govzilla team.

Post by Jane Wastl |

Recent Statement Regarding ARB Recalls

Yesterday, Dr. Janet Woodcock, FDA Director of the Center for Drug Evaluation and Research, released a statement regarding the recent recalls of Angiotensin II Receptor Blockers (ARB).

Post by FDAzilla |

Gaining GMP Expertise: Govzilla Adds Jerry Chapman as Senior GMP Quality Expert

Govzilla announces the addition of Jerry Chapman as Senior GMP Quality Expert to the Govzilla team.